Monoclonal antibodies (mAbs) make up one of the most important classes of advanced biotherapies. To find out about the current challenges and advances in the production of mAbs, GEN talked with Lukas ...
Innovative bioprocessing technologies are needed to make monoclonal antibody (mAb) production cheaper, according to new research, which suggests lowering the cost of goods (COGs) for mAb-based ...
RADNOR, Pa. and DUBLIN, Nov. 6, 2019 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR) and the National Institute of Bioprocessing Research and Training (NIBRT) today announced they are teaming up to address ...
Antibodies are Y-shaped protective proteins manufactured by B lymphocytes in reaction to invading pathogens. When B lymphocytes encounter foreign antigens expressed by antigen-presenting cells (e.g.
Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...
Many early workflows lack scalability, relying on temperature-sensitive steps, outdated purification tools or unnecessary customization. These design flaws often derail timelines and inflate costs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results